Advanced Accelerator Applications to Build Targeted RadioLigand Therapy Production Facility in Indianapolis
Congrès national GTE (groupe d’études des tumeurs endocrines)
Advanced Accelerator Applications Announces Health Canada Approval of NETSPOT® Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours
Advanced Accelerator Applications Announces Start of Phase III Study Investigating Radioligand Therapy Lutathera® as First-Line Treatment in Patients with Advanced GEP-NETs
NANETS (North American Neuroendocrine Tumor Society) Annual Symposium
EANM (European Association of Nuclear Medicine) Annual Congress
EANM Focus 3 – Molecular Imaging and Theranostics in Neuroendocrine Tumours
